Equities

Biovica International AB

Biovica International AB

Actions
  • Price (EUR)0.211
  • Today's Change0.004 / 1.69%
  • Shares traded0.00
  • 1 Year change-66.55%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Apr 30 2024202420232022
ASSETS
Cash And Short Term Investments7911490
Total Receivables, Net3.331.551.98
Total Inventory2.201.361.53
Prepaid expenses3.182.761.61
Other current assets, total0.000.00--
Total current assets8812095
Property, plant & equipment, net8.111114
Goodwill, net------
Intangibles, net323740
Long term investments------
Note receivable - long term------
Other long term assets0.000.000.00
Total assets131172152
LIABILITIES
Accounts payable3.033.282.89
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.533.154.46
Other current liabilities, total1.432.042.01
Total current liabilities282416
Total long term debt4.307.308.78
Total debt7.831013
Deferred income tax2.182.712.67
Minority interest------
Other liabilities, total0.00----
Total liabilities353428
SHAREHOLDERS EQUITY
Common stock5.603.051.90
Additional paid-in capital544464340
Retained earnings (accumulated deficit)(453)(328)(218)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.000.000.00
Total equity97139124
Total liabilities & shareholders' equity131172152
Total common shares outstanding844830
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.